NalaGenetics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
62
- Latest Deal Type
-
2ndary - Private
- Investors
-
17
NalaGenetics General Information
Description
Developer of a personalized prescription platform designed to offer accurate testing, impactful outcomes, and localized recommendations. The company's platform increases prescription efficacy through genetic testing and information management systems, enabling patients and decision-makers to have access to personalized information on how to interact with existing healthcare technologies.
Contact Information
Website
www.nalagenetics.comCorporate Office
- 1093 Lower Delta Road
- Number 04-05/06/07/08
- Singapore, 169204
- Singapore
Corporate Office
- 1093 Lower Delta Road
- Number 04-05/06/07/08
- Singapore, 169204
- Singapore
NalaGenetics Timeline
NalaGenetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 12. Accelerator/Incubator | 20-Apr-2026 | Completed | Generating Revenue | |||
| 11. Grant | 01-Jan-2025 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 12-Dec-2023 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 18-Oct-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 04-Jul-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 25-Mar-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 03-Feb-2022 | $3.04M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 01-Apr-2021 | $2.04M | $3.04M | Completed | Generating Revenue |
NalaGenetics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
NalaGenetics Comparisons
Industry
Financing
Details
NalaGenetics Competitors (24)
One of NalaGenetics’s 24 competitors is InformedDNA, a Venture Capital-Backed company based in Saint Petersburg, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InformedDNA | Venture Capital-Backed | Saint Petersburg, FL | ||||
| TellmeGen | Formerly Accelerator/Incubator backed | Valencia, Spain | ||||
| YouScript | Formerly VC-backed | Houston, TX | ||||
| Genome Medical | Venture Capital-Backed | South San Francisco, CA | ||||
| OmeCare | Formerly VC-backed | San Diego, CA |
NalaGenetics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NalaGenetics Patents
NalaGenetics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4305199-A1 | A method for assessing the potential effect of therapeutics on an individual | Inactive | 11-Mar-2021 | ||
| EP-4305199-A4 | A method for assessing the potential effect of therapeutics on an individual | Inactive | 11-Mar-2021 | ||
| US-20240301501-A1 | A method for assessing the potential effect of therapeutics on an individual | Inactive | 11-Mar-2021 | ||
| WO-2022191780-A1 | A method for assessing the potential effect of therapeutics on an individual | Inactive | 11-Mar-2021 | C12Q1/6886 |
NalaGenetics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NalaGenetics Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IHH Catalyst | Accelerator/Incubator | |||
| SLINGSHOT (Singapore) | Other | |||
| Zurich Innovation Championship | Accelerator/Incubator | |||
| Google Accelerator | Accelerator/Incubator | |||
| Scaler8 | Accelerator/Incubator |
NalaGenetics FAQs
-
When was NalaGenetics founded?
NalaGenetics was founded in 2016.
-
Where is NalaGenetics headquartered?
NalaGenetics is headquartered in Singapore, Singapore.
-
What is the size of NalaGenetics?
NalaGenetics has 62 total employees.
-
What industry is NalaGenetics in?
NalaGenetics’s primary industry is Other Healthcare Services.
-
Is NalaGenetics a private or public company?
NalaGenetics is a Private company.
-
What is NalaGenetics’s current revenue?
The current revenue for NalaGenetics is .
-
How much funding has NalaGenetics raised over time?
NalaGenetics has raised $15.7M.
-
Who are NalaGenetics’s investors?
IHH Catalyst, SLINGSHOT (Singapore), Zurich Innovation Championship, Google Accelerator, and Scaler8 are 5 of 17 investors who have invested in NalaGenetics.
-
Who are NalaGenetics’s competitors?
InformedDNA, TellmeGen, YouScript, Genome Medical, and OmeCare are some of the 24 competitors of NalaGenetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
